DiLunBio: Abokin Hulɗar ku Mai Aminci a Tsarin Peptide Mai Aiki da Kai

Tushenmu

Kamfanin Beijing Dilun Biotechnology Co., Ltd. yana da asali ɗaya da Kamfanin Peptide Scientific Inc. (PSI), Amurka, tana aiki a matsayin sashin faɗaɗawa da haɓaka ta a China. Tun lokacin da aka kafa ta a shekarar 2012, Dilun Bio ta gaji tsarin DNA na fasaha da gudanarwa na PSI, yayin da kuma ta haɓaka kirkire-kirkire ta hanyar bincike mai zaman kansa - wanda ya ƙware a haɓaka da kera Kayan aikin haɗa peptide mai ƙarfi-lokaci.

Ƙirƙira Mai Zaman Kanta

DiLun Bio ta ƙirƙiro kayan aiki masu mahimmanci da kanta, ciki har da masu haɗa peptide kuma Tsarin raba peptide, gina cikakken tsarin kayan aiki wanda ke tallafawa hada peptide daga bincike zuwa haɓaka gwaji da kuma samar da masana'antu. Kamfanin ya himmatu wajen samar da ingantattun hanyoyin samar da peptide masu inganci, masu wayo, kuma masu amfani da muhalli ga al'ummar kimiyya da magunguna ta duniya.

Falsafar Zane

Falsafar ƙira ta Dilun Bio ta samo asali ne daga kiyaye makamashi, dorewar muhalli, da kuma kera kayayyaki masu wayo. Fasahar zamani ta haɗa da:

· Sake amfani da sinadarin da ke narkewa da kuma rage sharar gida
· Dumama mai amfani da microwave, mai amfani da makamashi mai kyau
· Gudanar da dijital don ingantaccen aiki
· Aikin tashoshi da yawa na Asynchronous & sarrafa mai wayo na nesa

Waɗannan sabbin abubuwa suna haɓaka ingancin makamashi, rage fitar da hayakin carbon, kuma suna ba da damar ƙirƙirar tsarin samar da peptide da aka haɗa waɗanda ke aiki a cikin inganci, ƙarancin amfani, kuma kore.

Karɓar Tallafi a Duniya

Zuwa yanzu, an yi amfani da kayan aikin Dilun Bio ta hanyar Cibiyoyin ilimi sama da 50 kuma Kamfanonin harhada magunguna 30+ a faɗin ƙasar Sin, ciki har da Jami'ar Peking, Jami'ar Tsinghua, Hengrui Pharma, da kuma Yangtze River Pharmaceutical Group. Haka kuma ana fitar da kayayyaki zuwa ƙasashen waje. Kasashe 10+ kamar Amurka, Jamus, Ostiraliya, da Girka, tare da ci gaba da faɗaɗa tushen abokan ciniki na duniya.

Ganin Gaba

Dilun Bio za ta ci gaba da riƙe falsafar ta tarihi da kirkire-kirkire, masana'antu masu wayo, ingantaccen aiki, da ci gaba tareyana ba da gudummawa ga kimiyyar rayuwa ta duniya da masana'antun magunguna ta hanyar mafita mai dorewa, mai inganci.Da yake muna sa ran, Dilun Bio za ta goyi bayan falsafar "gado da kirkire-kirkire, masana'antu masu wayo, ingantaccen aiki, da ci gaba tare," kuma za ta ci gaba da bincika sabbin fannoni a cikin fasahar hada peptide, tana ba da gudummawa ga kimiyyar rayuwa ta duniya da masana'antar magunguna ta hanyar mafita mai dorewa da inganci.

Abin da Muke Tsayuwa a Kai

Mu injiniyoyi ne na duniyar kwayoyin halitta kuma masu taimakawa ci gaban kimiyyar rayuwa.

A cikin wannan zamani da bayanai ke jagoranta kuma aka ayyana ta hanyar ganowa, mun himmatu wajen gina dandamalin hada peptide daidai, inganci, da inganci. Fasaharmu tana tallafawa masu bincike, masu haɓaka magunguna, da masu kirkire-kirkire a fannin fasahar halittu a duk duniya—wanda ke ba su damar buɗe sirrin da ke zuciyar rayuwa.

Kowace sarkar peptide jumla ce a cikin harshen rayuwa.

Rayuwa ta wuce ta ɗan adam. A matsayin ƙwayoyin sigina, masu tsara dokoki, da kuma magungunan warkarwa, peptides suna taka muhimmiyar rawa a cikin mutane, dabbobi, tsirrai, da ƙananan halittu.
Kayan aikinmu ba wai kawai suna haɗa ƙwayoyin halitta ba ne—suna taimaka wa masana kimiyya su ba da labarin rayuwa, dawo da lafiya, bincika juyin halitta, da kuma haɗa hankali tsakanin nau'ikan halittu.

Muna haɗa ƙananan abubuwa da ma'ana—muna sa rayuwa ta zama mai ma'ana, mai sauƙin fahimta, kuma mai daraja.

Ko dai yana ba da damar samun ci gaba a fannin ilimin halittar jiki, inganta lafiyar dabbobin gida, inganta garkuwar jiki ga tsirrai, ko kuma haɓaka hanyoyin magance ƙwayoyin cuta masu cutarwa ga muhalli—kimiyyar peptide tana kan gaba a fannin ilimin halittar zamani.
Muna tsaye a matsayin abokin fasaha ga kimiyya, muna ba da mafita mai ƙarfi don samar da ingantacciyar duniya mai lafiya, wayo, da kuma sanin muhalli.

Peptides hanya ce ta bayyana ƙauna da kariya ga rayuwa. Ta hanyar kimiyya da fasaha, muna yin fiye da haɗa ƙwayoyin halitta—muna haɗa rayuka, muna ƙarfafa bege, kuma muna ɗaukaka bambancin halittu.

Idan muka duba gaba, Dilun Bio za ta ci gaba da jajircewa kan muhimman dabi'unta: gado da kirkire-kirkire, masana'antu masu wayo, ingantaccen aiki, da kuma ci gaban hadin gwiwa. Muna da burin zama jagora a duniya kuma jagora a fannin kirkire-kirkire a cikin kayan aikin hada peptide mai karfi. Tare da jagorancin ka'idar hadawa mai dorewa da inganci, muna samar da ingantattun mafita, masu dacewa da yanayi ga kimiyyar rayuwa da masana'antar magunguna. Za mu ci gaba da tura iyakokin fasahar peptide da kuma ba da gudummawa ga kyakkyawar makoma ga yanayin kimiyyar rayuwa ta duniya.

Alamun Abokan Hulɗa

Kamfanin Advanced ChemTech (ACT) ya ba Dilun Bio izinin zama mai samar da ayyukan kula da sinadarai masu samar da sinadarai masu hana peptide a babban yankin kasar Sin. Dilun Bio tana da alhakin tallafawa tallace-tallace, shigarwa, horar da fasaha, da ayyukan bayan tallace-tallace, yana tabbatar da cewa abokan cinikin kasar Sin sun sami tallafi na kwararru da kuma ayyukan kayan aiki masu inganci.

Kamfanin Analytical Technologies Limited kamfani ne mai fasaha a ƙasashe sama da 96, wanda ya ƙware a fannin nazarin bayanai, nazarin chromatography, spectroscopy, biotechnology, biomedical, ganewar asibiti, da kayan aikin kimiyyar kayan aiki. Jerin samfuranmu sun haɗa da saitunan dakin gwaje-gwaje na turnkey, tsarin HPLC/GC/IC, jerin LCMS/GCMS/ICPMS, MALDI-TOF, ICP-OES, FTIR, SEM/TEM/XRD/XRF, MRI/CT, masu nazarin hematology & biochemistry, PCR/RT-PCR, tsarin ELISA, masu nazarin barbashi, DSC/TGA, da ƙari. Analytical Technologies Limited (Indiya) ita ce wakilinmu mai izini, wanda ke da alhakin tallace-tallace da tallata kayayyakinmu a Indiya da kasuwannin duniya.

Ƙungiyarmu

Peptide Scientific Inc. (PSI) wani kamfani ne mai fasaha mai zurfi da ke Amurka wanda ya ƙware a fannin bincike da samar da kayan aikin haɗa peptide. PSI tana ba da cikakkun hanyoyin samar da peptide masu wayo ga cibiyoyin bincike na duniya da kamfanonin magunguna, waɗanda suka shafi bincike da haɓaka da haɓaka dakunan gwaje-gwaje, gwajin gwaji, da kuma samar da masana'antu. Manyan fasahohinta sun haɗa da haɗakar juyawa mai zurfi 180° da ƙira mai sassauƙa, suna saita ma'auni don inganci da ingancin samfura.

Fasahar zamani ta PSI ta haɗu da sabbin fasahohi da ayyukan Dilun Bio na gida ba tare da wata matsala ba. Tare da asali iri ɗaya da kuma ƙa'idodi masu daidaito, Dilun Bio ta kawo fasahar zamani ta PSI zuwa China, tana samar wa abokan cinikin gida mafita mafi kyau na peptide synthesizer da kuma cimma ci gaba da fasaha da ci gaba mai ɗorewa.

A Dilun Bio, muna haɗa ƙungiyar ƙwararru da ta ƙware a fannin bincike da haɓaka kayan aikin peptide, injiniyanci, da tallafin abokin ciniki. Tare da zurfin gogewa a masana'antu da ƙwarewar aiki, muna ba da cikakkun ayyuka waɗanda suka haɗa da zaɓar kayan aiki, ƙirar mafita ta musamman, shigarwa a wurin, horar da fasaha, da tallafin bayan tallace-tallace.

Abokan Cinikinmu

Ana amfani da kayayyakin Dilun Bio sosai a manyan cibiyoyin bincike kamar Jami'ar Peking, Jami'ar Tsinghua, Jami'ar Jiao Tong ta Shanghai, Jami'ar Sichuan, Jami'ar Lanzhou, da Jami'ar Fasaha ta Kudancin China. Manyan kamfanonin magunguna kamar Hengrui Pharma, Yangtze River Pharmaceutical Group, da Hansoh Pharma sun amince da su.
Bugu da ƙari, an fitar da kayan aikin Dilun Bio zuwa ƙasashe da suka haɗa da Amurka, Jamus, Girka, Iran, Ostiraliya, New Zealand, Japan, da Rasha—wanda hakan ya sa suka sami suna mai ƙarfi a duniya da kuma faɗaɗa isa ga kasuwar duniya.

010203

2003:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2004:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2005:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2006:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2007:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

0102030405

2008:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2009:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2010:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2011:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2012:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

0102030405

Tarihinmu

Manyan abubuwan tarihi da suka faru

1995-2025

1995:

Dr. John Ye ya gabatar da yanayin haɗa reactor mai juyi na 180°, yana kawar da lalacewar resin daga juyawar injina da kuma cimma ingancin haɗin gwiwa sama da kashi 99.5%.

2000:

PSI ta ƙirƙiro wani tsarin tattara bayanai na lantarki da sa hannu na FDA 21 CFR Part 11 wanda ya dace da ka'idojin FDA don tabbatar da tsaro da bin ƙa'idodi na gudanar da bayanai.

2001:

PSI ta ƙirƙiro fasahar sake zagayowar sinadarai masu narkewa ta rage amfani da sinadarai da ɓarna da kashi 40%, kuma ta ƙera na'urar haɗa peptide mai bakin ƙarfe 316L mai cikakken sarrafa kansa.

2002:

An kafa Peptide Scientific Inc., inda aka ƙaddamar da sinadarin PSI500 wanda ya haɗa haɗakar inversion, sake amfani da sinadarai masu narkewa, software na bin ƙa'ida, da ƙirar bakin ƙarfe don samar da peptide mai tsayi.

2012:

PSI ta kafa fasahar kere-kere ta Beijing Dilun domin ci gaba da bunkasa fasaharta ta zamani da kuma zama babban dandamalin ci gaba a nan gaba.

2015:

Kamfanin PSI ya ƙaddamar da wani kayan aikin raba peptide wanda aka tsara shi don kasuwar China, inda ya kammala cikakken aikin sa na bincike da haɓaka kayan aiki.

2025:

PSI ta gabatar da sinadarin peptide mai suna asynchronous microscale microscale 386 Pro twelve-channel, wanda ke ba da damar haɗakar tashoshi masu zaman kansu da kuma samar da peptide mai rikitarwa mai ƙarfi.

01020304050607

2000:

PSI ta ƙirƙiro wani tsarin tattara bayanai na lantarki da sa hannu na FDA 21 CFR Part 11 wanda ya dace da ka'idojin FDA don tabbatar da tsaro da bin ƙa'idodi na gudanar da bayanai.

2004:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2005:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2006:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2007:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

0102030405

2001:

2009:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2010:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2011:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2012:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

0102030405

2002:

2009:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2010:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2011:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2012:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

0102030405

2012:

PSI ta kafa fasahar kere-kere ta Beijing Dilun domin ci gaba da bunkasa fasaharta ta zamani da kuma zama babban dandamalin ci gaba a nan gaba.

2009:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2010:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2011:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

2012:

Kafa Hybio Pharmaceutical, wanda ke nuna farkon tafiyarmu.

0102030405

2015:

Kamfanin PSI ya ƙaddamar da wani kayan aikin raba peptide wanda aka tsara shi don kasuwar China, inda ya kammala cikakken aikin sa na bincike da haɓaka kayan aiki.